154 related articles for article (PubMed ID: 27832498)
1. Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe.
Bogdanova N; Pfeifer K; Schürmann P; Antonenkova N; Siggelkow W; Christiansen H; Hillemanns P; Park-Simon TW; Dörk T
Fam Cancer; 2017 Apr; 16(2):181-186. PubMed ID: 27832498
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of germline mutations in breast cancer genes: RECQL.
Bowden AR; Tischkowitz M
Breast Cancer Res Treat; 2019 Apr; 174(3):553-560. PubMed ID: 30610487
[TBL] [Abstract][Full Text] [Related]
3. FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine.
Nguyen-Dumont T; Myszka A; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
BMC Med Genet; 2018 Jan; 19(1):12. PubMed ID: 29351780
[TBL] [Abstract][Full Text] [Related]
4. Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
Sun J; Wang Y; Xia Y; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lou H; Xie Y
PLoS Genet; 2015 May; 11(5):e1005228. PubMed ID: 25945795
[TBL] [Abstract][Full Text] [Related]
5. Germline RECQL mutations are associated with breast cancer susceptibility.
Cybulski C; Carrot-Zhang J; Kluźniak W; Rivera B; Kashyap A; Wokołorczyk D; Giroux S; Nadaf J; Hamel N; Zhang S; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Rudnicka H; Lener M; Masojć B; Tonin PN; Rousseau F; Górski B; Dębniak T; Majewski J; Lubiński J; Foulkes WD; Narod SA; Akbari MR
Nat Genet; 2015 Jun; 47(6):643-6. PubMed ID: 25915596
[TBL] [Abstract][Full Text] [Related]
6. RECQL: a DNA helicase in breast cancer.
Akbari MR; Cybulski C
Oncotarget; 2015 Sep; 6(29):26558-9. PubMed ID: 26387136
[No Abstract] [Full Text] [Related]
7. Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.
Tervasmäki A; Mantere T; Hartikainen JM; Kauppila S; Lee HM; Koivuluoma S; Grip M; Karihtala P; Jukkola-Vuorinen A; Mannermaa A; Winqvist R; Pylkäs K
Int J Cancer; 2018 Jun; 142(11):2286-2292. PubMed ID: 29341116
[TBL] [Abstract][Full Text] [Related]
8. Germline RECQL mutations in high risk Chinese breast cancer patients.
Kwong A; Shin VY; Cheuk IWY; Chen J; Au CH; Ho DN; Chan TL; Ma ESK; Akbari MR; Narod SA
Breast Cancer Res Treat; 2016 Jun; 157(2):211-215. PubMed ID: 27125668
[TBL] [Abstract][Full Text] [Related]
9. Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations.
Prokofyeva D; Bogdanova N; Dubrowinskaja N; Bermisheva M; Takhirova Z; Antonenkova N; Turmanov N; Datsyuk I; Gantsev S; Christiansen H; Park-Simon TW; Hillemanns P; Khusnutdinova E; Dörk T
Breast Cancer Res Treat; 2013 Jan; 137(2):533-9. PubMed ID: 23225144
[TBL] [Abstract][Full Text] [Related]
10. RECQL: a new breast cancer susceptibility gene.
Banerjee T; Brosh RM
Cell Cycle; 2015; 14(22):3540-3. PubMed ID: 26125302
[TBL] [Abstract][Full Text] [Related]
11. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Hillemanns P; Dörk T
Clin Genet; 2010 Oct; 78(4):364-72. PubMed ID: 20569256
[TBL] [Abstract][Full Text] [Related]
12. Allelic variants of breast cancer susceptibility genes
Hilz P; Heinrihsone R; Pätzold LA; Qi Q; Trofimovics G; Gailite L; Irmejs A; Gardovskis J; Miklasevics E; Daneberga Z
Hered Cancer Clin Pract; 2019; 17():17. PubMed ID: 31312277
[TBL] [Abstract][Full Text] [Related]
13. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
Antczak A; Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Nagorna A; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Domagała P; Stawicka M; Milecki P; Akbari MR; Narod SA; Lubiński J; Cybulski C; ; ; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała W; Chosia M; van de Wetering T; Serrano-Fernández P; Puszyński M; Soczawa M; Switała J; Archimowicz S; Kordowski M; Zyczkowski M; Borówka A; Bagińska J; Krajka K; Szwiec M; Haus O; Janiszewska H; Stembalska A; Sąsiadek MM
Gene; 2013 Dec; 532(2):173-6. PubMed ID: 24096176
[TBL] [Abstract][Full Text] [Related]
14. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
Bogdanova N; Feshchenko S; Schürmann P; Waltes R; Wieland B; Hillemanns P; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Varon R; Dörk T
Int J Cancer; 2008 Feb; 122(4):802-6. PubMed ID: 17957789
[TBL] [Abstract][Full Text] [Related]
15. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
Bogdanova N; Cybulski C; Bermisheva M; Datsyuk I; Yamini P; Hillemanns P; Antonenkova NN; Khusnutdinova E; Lubinski J; Dörk T
Breast Cancer Res Treat; 2009 Nov; 118(1):207-11. PubMed ID: 18807267
[TBL] [Abstract][Full Text] [Related]
16. Association of two mutations in the CHEK2 gene with breast cancer.
Bogdanova N; Enssen-Dubrowinskaja N; Feshchenko S; Lazjuk GI; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Dörk T
Int J Cancer; 2005 Aug; 116(2):263-6. PubMed ID: 15810020
[TBL] [Abstract][Full Text] [Related]
17. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
[TBL] [Abstract][Full Text] [Related]
18. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe.
Bogdanova N; Togo AV; Ratajska M; Kluźniak W; Takhirova Z; Tarp T; Prokofyeva D; Bermisheva M; Yanus GA; Gorodnova TV; Sokolenko AP; Kuźniacka A; Podolak A; Stukan M; Wokołorczyk D; Gronwald J; Vasilevska D; Rudaitis V; Runnebaum IB; Dürst M; Park-Simon TW; Hillemanns P; Antonenkova N; Khusnutdinova E; Limon J; Lubinski J; Cybulski C; Imyanitov E; Dörk T
Fam Cancer; 2015 Mar; 14(1):145-9. PubMed ID: 25182961
[TBL] [Abstract][Full Text] [Related]
20. Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer.
Radmanesh H; Spethmann T; Enßen J; Schürmann P; Bhuju S; Geffers R; Antonenkova N; Khusnutdinova E; Sadr-Nabavi A; Shandiz FH; Park-Simon TW; Hillemanns P; Christiansen H; Bogdanova N; Dörk T
Breast Cancer Res Treat; 2017 Feb; 162(1):31-37. PubMed ID: 28062980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
